Financhill
Back

BioXcel Therapeutics Vs. 4D Molecular Therapeutics Industry Stock Comparison

Sell
24

BTAI
BioXcel Therapeutics

Last Price:
2.61
Seasonality Move:
13.65%
Sell
16

FDMT
4D Molecular Therapeutics

Last Price:
23.21
Seasonality Move:
-20.46%
Sell
24
BioXcel Therapeutics (BTAI) is a Sell

Is BioXcel Therapeutics a Buy, Sell or Hold?

  • The current BioXcel Therapeutics [BTAI] share price is $2.63. The Score for BTAI is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • BTAI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
4D Molecular Therapeutics (FDMT) is a Sell

Is 4D Molecular Therapeutics a Buy, Sell or Hold?

  • The current 4D Molecular Therapeutics [FDMT] share price is $23.25. The Score for FDMT is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • FDMT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BTAI Stock Price Chart

What is BioXcel Therapeutics's stock price today?

  • The BioXcel Therapeutics share price today is $2.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing buying pressure, which is a positive indicator for future bullish movement.

FDMT Stock Price Chart

What is 4D Molecular Therapeutics's stock price today?

  • The 4D Molecular Therapeutics share price today is $23.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight selling pressure.

BTAI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 45.09 Sell
Chaikin Money Flow: 180011 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.61 - 2.85) Sell
Bollinger Bands (100): (2.61 - 3.33) Sell

FDMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.44 Sell
Relative Strength Index (14 RSI): 34.11 Sell
Chaikin Money Flow: -30640 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.57 - 31.31) Sell
Bollinger Bands (100): (18.43 - 29.93) Sell

BTAI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.71 Sell
20-day SMA: 2.7 Sell
50-day SMA: 2.9 Sell
200-day SMA: 3.9 Sell
8-day EMA: 2.71 Sell
20-day EMA: 2.73 Sell
50-day EMA: 2.85 Sell
200-day EMA: 5.59 Sell

FDMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.7 Sell
20-day SMA: 26.48 Sell
50-day SMA: 28.52 Sell
200-day SMA: 19.19 Buy
8-day EMA: 24.68 Sell
20-day EMA: 26.35 Sell
50-day EMA: 26.76 Sell
200-day EMA: 21.52 Buy

BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.34 per share, and an increase next year of $1.29 per share.

4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.

BioXcel Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

4D Molecular Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):